The pharmaceutical packaging materials market includes the following segments: plastic, glass, and others, including aluminum, rubber, and paper. According to the type of final product, the market is divided into oral drugs, drops and sprays, topical drugs and suppositories, and injections.
New York, August 23, 2021 (GLOBE NEWSWIRE) – Reportlinker.com announced the release of “Global Pharmaceutical Packaging Material Growth Opportunities” report-Packaging play in the pharmaceutical industry It plays a key role in protecting and maintaining the stability of the drug during storage, transportation and use. Although the packaging materials of medicine are mainly divided into primary, secondary and tertiary, primary packaging is very important because it directly touches the effective primary packaging based on polymer, glass, aluminum, rubber and paper in the pharmaceutical industry. Materials (such as bottles, blister and strip packaging, ampoules and vials, prefilled syringes, cartridges, test tubes, cans, caps and closures, and sachets) can prevent drug contamination and improve patient compliance. Terials will account for the largest share of the global pharmaceutical packaging materials market in 2020 and is expected to maintain its dominant position during the forecast period. This is mainly due to the use of polyvinyl chloride (PVC), polyolefin (PO), and polyethylene terephthalate (PET) for cost-effective packaging of various over-the-counter (OTC) drugs. Compared with traditional packaging materials, plastic packaging is very lightweight, cost-effective, inert, flexible, hard to break, and easier to handle, store, and transport drugs. In addition, plastic can be easily molded into various shapes, and it also provides a wide range of attractive packaging options to facilitate identification of drugs. The increasing demand for over-the-counter drugs is one of the main driving factors for global plastic-based pharmaceutical packaging materials. In addition, 3D printing technology is expected to gradually revolutionize the medical plastic packaging industry in terms of rapid prototyping, high design flexibility and shortened development time in the future. Due to its excellent barrier properties and the ability to withstand severe pH, it is a traditional material used to store and distribute highly reactive drugs and complex biological agents. In addition, glass has excellent impermeability, inertness, sterility, transparency, high temperature stability and UV resistance, and is mainly used to make value-added vials, ampoules, prefilled syringes and amber bottles. In addition, the pharmaceutical glass packaging material market has experienced huge demand in 2020, especially glass vials, which are increasingly used to store and distribute COVID-19 vaccines worldwide. As governments around the world step up efforts to vaccinate people with the deadly coronavirus, these glass vials are expected to significantly boost the entire glass packaging material market in the next 1-2 years. Other materials, such as aluminum blister packs, tubes, and paper strip packaging are also experiencing fierce competition from plastic alternatives, but aluminum products may continue to grow strongly in the packaging of sensitive drugs, which require long periods of large amounts of moisture and Oxygen barrier. On the other hand, rubber caps are widely used for effective sealing of various medical plastic and glass containers. Developing countries, especially those in the Asia-Pacific, Middle East and North America and Latin America, are experiencing rapid economic development and urbanization. In the past few years, the incidence of lifestyle diseases in these countries has increased significantly, leading to an increase in health care expenditures. These economies have also become prominent low-cost drug manufacturing centers, especially various non-prescription drug preparations such as digestive agents, paracetamol, analgesics, contraceptives, vitamins, iron supplements, antacids and cough syrups. These factors, in turn, have stimulated including China, India, Malaysia, Taiwan, Thailand, Vietnam, Indonesia, India, Saudi Arabia, Brazil and Mexico. As the demand for advanced drug delivery methods continues to increase, pharmaceutical companies in the Americas and Europe are highly focused on the development of high-priced composite biologics and other highly reactive injection drugs, such as tumor drugs, hormone drugs, vaccines, and oral drugs. Proteins, monoclonal antibodies, and cell and gene therapy drugs with better therapeutic effects. These sensitive parenteral preparations usually require high value-added glass and plastic packaging materials to provide excellent barrier properties, transparency, durability, and drug stability during storage, transportation, and use. In addition, it is expected that the efforts of advanced economies to reduce their carbon.
Post time: Aug-23-2021